Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• The Future of Drug Safety: Promoting and Protecting the Health of the Public (ISBN ) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Safe Medical Devices for Children (ISBN ) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (ISBN ) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary (ISBN ) Forum on Drug Discovery, Development, and Translation, Leslie Pray, Rapporteur


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Leadership Commitments to Improve Value in Health Care:Finding Common Ground: Workshop Summary (ISBN ) LeighAnne Olsen, W. Alexander Goolsby, and J. Michael McGinnis; Roundtable on Evidence-Based Medicine


• Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making:Workshop Report (ISBN ) Jonathan R. Davis, Vivian P. Nolan, Janet Woodcock, and Ronald W. Estabrook, Editors; Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Institute of Medicine


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (ISBN ) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (ISBN ) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Food and Drug Administration Advisory Committees (ISBN ) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• The Ethical Conduct of Clinical Research Involving Children (ISBN ) Marilyn J. Field and Richard E. Berman, Editors, Committee on Clinical Research Involving Children


• Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary (ISBN ) Steve Olson and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (ISBN ) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council


• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (ISBN ) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (ISBN ) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration (ISBN )


• An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program (ISBN ) Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program


• Scientific Standards for Studies on Modified Risk Tobacco Products (ISBN ) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Assessing and Improving Value in Cancer Care:Workshop Summary (ISBN ) Adam Schickedanz, Rapporteur; Institute of Medicine


• Responsible Research:A Systems Approach to Protecting Research Participants (ISBN ) Daniel D. Federman, Kathi E. Hanna, and Laura Lyman Rodriguez, Editors, Committee on Assessing the System for Protecting Human Research Participants


• Informing the Future: Critical Issues in Health, Fourth Edition (ISBN )


• Assessing Medical Technologies (ISBN ) Committee for Evaluating Medical Technologies in Clinical Use, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (ISBN ) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• Genome-Based Therapeutics:Targeted Drug Discovery and Development: Workshop Summary (ISBN ) Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions:Issues for the Government and Private Sector (ISBN ) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Halcion:An Independent Assessment of Safety and Efficacy Data (ISBN ) Committee on Halcion: An Assessment of Data Adequacy and Confidence, Division of Health Sciences Policy, Institute of Medicine


• Dietary Supplements: A Framework for Evaluating Safety (ISBN ) Committe on the Framework for Evaluating the Safety of the Dietary Supplements, National Research Council


• A Report on the Sponsors of Cancer Treatment Clinical Trials and Their Approval and Monitoring Mechanisms (ISBN )


• Ethical Issues in Studying the Safety of Approved Drugs:A Letter Report (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs


• Expanding Access to Investigational Therapies for HIV Infection and AIDS (ISBN ) Roundtable for the Development of Drugs and Vaccines Against AIDS, Institute of Medicine


• A Foundation for Evidence-Driven Practice:A Rapid Learning System for Cancer Care: Workshop Summary (ISBN ) Sharon Murphy and Margie Patlak, Rapporteurs; Institute of Medicine


• Preventing Medication Errors: Quality Chasm Series (ISBN ) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• The Changing Economics of Medical Technology (ISBN ) Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine


• Developing New Contraceptives:Obstacles and Opportunities (ISBN ) Committee on Contraceptive Development, National Research Council and Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (ISBN ) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine